Panelists discuss an Einstein innovation moving from "bench to bedside." Einstein-invented technology intended to treat metastatic melanoma is in clinical trials by Pain Therapeutics, Inc. Panelists include: Ekaterina Dadachova, Ph.D., the Sylvia & Robert S. Olnick Faculty Scholar in Cancer Research; John Harb, director of the office of biotechnology; and Remi Barbier,CEO of Pain Therapeutics, Inc. (September 24, 2009)
